Profiel
Tracy Cunningham is currently the Director at Health Research Board and the Chief Medical Officer at Amryt Pharma Plc.
Previously, she worked as the Clinical Head-Oncology Research & Development at AstraZeneca PLC and as the Vice President & Head-Development at Amryt Pharma Holdings Ltd. Dr. Cunningham completed her undergraduate degree at the Royal College of Surgeons.
Actieve functies van Tracy Cunningham
| Bedrijven | Functie | Begin |
|---|---|---|
| AMRYT PHARMA PLC | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Directeur/Bestuurslid | - |
Eerdere bekende functies van Tracy Cunningham
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Tracy Cunningham
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Government |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
















